Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
KDx Diagnostics develops diagnostic tests for early detection and management of cancer, including the URO17 non-invasive urine test for bladder cancer based on the Keratin 17 biomarker. The URO17 test is offered in the US as a Laboratory Developed Test through reference laboratories and as a CE-IVD kit outside the US.
0 investors
Kelyniam manufactures custom cranial and craniofacial implants for surgical specialists and hospitals, featuring patented Integrated Fixation System tabs and 24-48 hour production turnaround using 3D printing technology. The company also distributes complementary bone substitute products and operates as a medical device manufacturer focused on the osteointegrative implant market.
0 investors
KeraNetics develops keratin-based medical products for wound care, with its lead product KeraStat Cream, an FDA-cleared prescription treatment for managing radiation dermatitis in cancer patients undergoing radiotherapy. The company originated from work with the Wake Forest Institute for Regenerative Medicine to treat battlefield injuries and serves patients and healthcare providers in oncology.
0 investors
KIFFIK develops a platform with proprietary K-EXP™ technology to enable direct access to interstitial fluid for biomarker discovery, drug development, and disease monitoring across oncology, neurology, metabolic conditions, and veterinary health.
0 investors
Kinomatic provides personalized orthopedic surgery planning that considers a patient's entire anatomy and biomechanics rather than treating each joint independently. The company optimizes surgical alignment to improve functional movement, reduce pain, and create more natural-feeling joints for patients undergoing hip, knee, and lower-body procedures.
0 investors
Kiora Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapies targeting retinal diseases to preserve, slow, or restore vision loss. The company focuses on critical pathways in eye disease for patients seeking advanced ophthalmologic treatments.
0 investors
Kodiak Sciences develops biopharmaceutical therapies for chronic ophthalmic diseases, with a focus on patient outcomes and stakeholder impact in the healthcare system.
0 investors
Koios Medical develops FDA-cleared, CE-marked AI software that assists physicians in diagnosing breast and thyroid cancer from ultrasound images. The product aims to reduce missed cancers and improve workflow efficiency for radiologists and clinical sites.
0 investors
Kromatid provides single-cell structural genomic analysis tools for cell and gene therapy companies, enabling assessment of genomic integrity and identification of complex structural rearrangements during therapy development. The company serves biotech and medtech organizations working on gene editing and cell therapy from early research through clinical trials.
0 investors
Kurin manufactures blood culture collection sets with contamination-reducing technology for healthcare providers. The company provides clinical support, data analytics, and outcomes measurement through proprietary platforms.
0 investors
Lakewood Amedex develops antimicrobial compounds, specifically Bisphosphocin® formulations, designed as locally delivered bactericides and fungicides with potential medical applications. The company focuses on advancing antimicrobial technology to address infection treatment needs.
0 investors
Laxco is a supplier of laboratory and scientific instruments, including life science and digital imaging products. It serves laboratory and research markets.
0 investors
Laxmi Therapeutic Devices develops wearable diabetes management technology to improve patient health outcomes and time in range.
0 investors
Levee Medical develops the Voro Urologic Scaffold, an absorbable medical device designed to reduce urinary incontinence in men following radical prostatectomy for prostate cancer. The device is in the research and development phase and not yet approved for sale.
0 investors
Levity Products develops medical devices for catheterization, originating from a solution created for a pediatric patient with spina bifida to reduce pain and infection. Its products include the LECS I device.
0 investors
LifeAire Systems designs medical grade air purification systems for sensitive healthcare environments such as IVF laboratories and other clinical care settings. It serves healthcare organizations worldwide.
0 investors
LIM Innovations develops the Infinite Socket, an adjustable, custom-molded prosthetic socket system for above-knee and below-knee amputees. Using its LIM CAPTURE process to create a 3D digital mold, the company serves clinicians and prosthetic patients in the medical device industry.
0 investors
Limber Prosthetics builds 3D-printed prosthetic devices and a digital scan-design-fabricate workflow for orthotics and prosthetics (O&P) clinicians. Its flagship product, the Px1, is a monolithic, fully alignable transtibial prosthesis designed individually per patient.
0 investors
LinguaFlex develops a minimally-invasive, investigational device placed in the underside of the tongue to treat obstructive sleep apnea and snoring by keeping the airway open during sleep. The device is placed in a 10-minute outpatient procedure under light sedation and is being evaluated for patients with sleep apnea; it has not yet received FDA clearance in the US.
0 investors
LIPAC Oncology is a pharmaceutical company developing chemotherapy treatments based on LiPax, a neoliposomal platform for local, targeted delivery of paclitaxel to treat intracavitary carcinomas. Its lead program targets non-muscle invasive bladder cancer, with additional indications in thoracic, upper tract urothelial, peritoneal, and ovarian cancers.
0 investors
Lirum Therapeutics is a biopharmaceutical company that acquires, develops, and commercializes novel drug candidates for the treatment of difficult-to-treat, debilitating diseases. It was created by the former management team of Stemline Therapeutics.
0 investors
Lixte develops cancer therapies, focusing on precision oncology and clinical drug development. The company works on advancing innovative treatments in the oncology field.
0 investors
Long Bridge Medical is developing the LensOne platform, a prosthetic capsular bag that provides stable, centered fixation of intraocular lenses (IOLs) in eyes lacking adequate capsular support and unsuited to anterior chamber IOLs. The investigational ophthalmic device targets surgeons treating IOL dislocation and secondary lens implantation.
0 investors
Longevity Medical Institute provides regenerative medicine, anti-aging therapies, and diagnostics for patients seeking personalized care. The clinic combines stem cell therapy, hormone optimization, aesthetic medicine, and advanced diagnostics with specialists across multiple disciplines to address age-related health conditions.
0 investors